BioGaia Management
Management criteria checks 4/4
BioGaia's CEO is Theresa Agnew, appointed in Sep 2023, has a tenure of 2.83 years. total yearly compensation is SEK9.21M, comprised of 54.8% salary and 45.2% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth $38.93K. The average tenure of the management team and the board of directors is 5.2 years and 4.7 years respectively.
Key information
Theresa Agnew
Chief executive officer
SEK 9.2m
Total compensation
| CEO salary percentage | 54.75% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.003% |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | SEK 332m |
| Dec 31 2025 | SEK 9m | SEK 5m | SEK 333m |
| Sep 30 2025 | n/a | n/a | SEK 316m |
| Jun 30 2025 | n/a | n/a | SEK 287m |
| Mar 31 2025 | n/a | n/a | SEK 310m |
| Dec 31 2024 | SEK 9m | SEK 5m | SEK 351m |
| Sep 30 2024 | n/a | n/a | SEK 337m |
| Jun 30 2024 | n/a | n/a | SEK 402m |
| Mar 31 2024 | n/a | n/a | SEK 371m |
| Dec 31 2023 | SEK 7m | SEK 1m | SEK 365m |
Compensation vs Market: Theresa's total compensation ($USD957.38K) is below average for companies of similar size in the US market ($USD5.14M).
Compensation vs Earnings: Theresa's compensation has been consistent with company performance over the past year.
CEO
Theresa Agnew (60 yo)
Ms. Theresa P. Agnew serves as President of BioGaia AB (publ) since September 2023 and serves as its Chief Executive Officer since 25 September 2023. She is a global business leader with consumer healthcar...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & President | 2.8yrs | SEK 9.21m | 0.0031% $ 38.9k | |
| Executive VP & CFO | 6.7yrs | SEK 3.66m | 0.0069% $ 86.6k | |
| Chief Operating Officer | 3.3yrs | no data | 0.0012% $ 15.5k | |
| Chief Scentific Officer | 6.5yrs | no data | no data | |
| Executive VP & Chief Legal Officer | 3.5yrs | no data | 0.00039% $ 4.9k | |
| Chief Marketing Officer | 5.2yrs | no data | 0.00019% $ 2.4k | |
| Chief Human Resources Officer | 7.5yrs | no data | 0.00049% $ 6.1k | |
| Managing Director Finland | no data | no data | no data | |
| Managing Director USA | no data | no data | no data | |
| Managing Director Canada | no data | no data | no data | |
| Managing Director UK & Ireland | no data | no data | no data | |
| Managing Director BioGaia Australia & New Zealand | no data | no data | no data |
Experienced Management: BGLA.F's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Deputy Board Chairman | 23.5yrs | SEK 653.00k | 0.86% $ 10.8m | |
| Chairman of the board | less than a year | SEK 352.00k | 0.73% $ 9.1m | |
| Independent Director | 3.2yrs | SEK 302.00k | 0.00049% $ 6.1k | |
| Independent Director | 11.2yrs | SEK 470.00k | 0.016% $ 198.1k | |
| Independent Director | 6.2yrs | SEK 373.00k | 0.00016% $ 2.0k | |
| Director | less than a year | no data | no data |
Experienced Board: BGLA.F's board of directors are considered experienced (4.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/07 05:50 |
| End of Day Share Price | 2026/06/24 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioGaia AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Uhde | ABG Sundal Collier Sponsored |
| Mattias Häggblom | Danske Bank |
| Kristofer Liljeberg-Svensson | DNB Carnegie |